Ngā hua rapu kaituhi :: APM

1

miRNA-target network reveals miR-124as a key miRNA contributing to clear cell renal cell carcinoma aggressive behaviour by targeting CAV1 and FLOT1 mā Henriett Butz, Péter M. Szabó, Heba Khella, Roy Nofech‐Mozes, Attila Patócs, George M. Yousef

I whakaputaina 2015

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
2

Micro<scp>RNA</scp>‐194 is a Marker for Good Prognosis in Clear Cell Renal Cell Carcinoma mā Roy Nofech‐Mozes, Heba Khella, Andreas Scorilas, Leza Youssef, Sergey N. Krylov, Evi Lianidou, Konstantinos Gus Sidiropoulos, Manal Gabril, Andrew Evans, George M. Yousef

I whakaputaina 2016

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
3

miR-221/222 Are Involved in Response to Sunitinib Treatment in Metastatic Renal Cell Carcinoma mā Heba Khella, Henriett Butz, Qiang Ding, Fabio Rotondo, Kenneth Evans, Peter Kupchak, Moyez Dharsee, Ashraf Latif, Maria Pasic, Evi Lianidou, Georg A. Bjarnason, George M. Yousef

I whakaputaina 2015

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
4

Low Expression of miR-126 Is a Prognostic Marker for Metastatic Clear Cell Renal Cell Carcinoma mā Heba Khella, Andreas Scorilas, Roy Mozes, Lorna Mirham, Evi Lianidou, Sergey N. Krylov, Jason Y. Lee, Michael Ordon, Robert Stewart, Michael A.S. Jewett, George M. Yousef

I whakaputaina 2015

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
5

miR-210 Is a Prognostic Marker in Clear Cell Renal Cell Carcinoma mā Sara Samaan, Heba Khella, Andrew H. Girgis, Andreas Scorilas, Evi Lianidou, Manal Gabril, Sergey N. Krylov, Michael A.S. Jewett, Georg A. Bjarnason, Hala El‐Said, George M. Yousef

I whakaputaina 2014

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
6

Multilevel Whole-Genome Analysis Reveals Candidate Biomarkers in Clear Cell Renal Cell Carcinoma mā Andrew H. Girgis, Vladimir V. Iakovlev, Ben Beheshti, Jane Bayani, Jeremy A. Squire, Anna Bui, Marina Mankaruos, Youssef Youssef, Bishoy Khalil, Heba Khella, Maria Pasic, George M. Yousef

I whakaputaina 2012

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
7

miRNA profiling in metastatic renal cell carcinoma reveals a tumour-suppressor effect for miR-215 mā Nicole M. White, Heba Khella, Jörg Grigull, Sonja Adzovic, Youssef M Youssef, R. John D’A. Honey, Robert Stewart, Kenneth T. Pace, Georg A. Bjarnason, Michael A.S. Jewett, Andrew Evans, Manal Gabril, George M. Yousef

I whakaputaina 2011

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
8

The Clinical Utility of miR-21 as a Diagnostic and Prognostic Marker for Renal Cell Carcinoma mā Hala Faragalla, Youssef M. Youssef, Andreas Scorilas, Bishoy Khalil, Nicole M. White, Salvador Mejia‐Guerrero, Heba Khella, Michael A.S. Jewett, Andrew Evans, Zsuzsanna Lichner, Georg A. Bjarnason, Linda Sugar, Magdy I. Attalah, George M. Yousef

I whakaputaina 2012

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
9

Therapeutic Targeting of TFE3/IRS-1/PI3K/mTOR Axis in Translocation Renal Cell Carcinoma mā Nur P. Damayanti, Justin A. Budka, Heba Khella, Mary W. Ferris, Sheng‐Yu Ku, Eric Kauffman, Anthony C. Wood, Khunsha Ahmed, Venkata Nithinsai Chintala, Remi Adelaiye‐Ogala, May Elbanna, Ashley Orillion, Sreenivasulu Chintala, Chinghai Kao, W. Marston Linehan, George M. Yousef, Peter C. Hollenhorst, Роберто Пили

I whakaputaina 2018

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i: